Most patients with decompensated cirrhosis who received inadequate prognostic information about their condition reported higher symptom burden and lower HRQOL.

Although all patients with NAFLD need aggressive management of cardiovascular risk factors, it is only patients with NASH who need treatment targeted at the liver disease. None of the currently ...

Nonalcoholic fatty liver disease (NAFLD) and its progressive form ... the pathogenesis of NAFLD and the current treatment and management of nonalcoholic steatohepatitis. Currently, maintaining ...

Some of the key participants present in the global Cirrhosis Management market include Theravance Biopharma R&D, Alliancells Bioscience Corporation Limited, B. Braun Medical Inc., Conatus ...

Besides weight loss, exercise can aid in reducing liver fat, improving inflammation biomarkers, and enhancing cardiovascular ...

L iver cirrhosis is a late-stage liver disease characterized by the gradual replacement of healthy liver tissue with scar tissue. This condition typically results from long-term chronic hepatitis ...

MASLD, previously known as non-alcoholic fatty liver disease (NAFLD), is a chronic liver disease that occurs when fat builds ...

Your liver performs over 500 essential functions to maintain your health, from detoxifying harmful substances to supporting ...

Cholesterol-lowering medications, like ezetimibe, may cut liver cancer risk by 31%. Discover how this breakthrough could help ...

Metabolic dysfunction-associated steatotic liver disease (MASLD), previously called non-alcoholic fatty liver disease, is a ...

Because the liver plays a vital role in digestion and nutrient absorption, individuals with cirrhosis are at risk of malnutrition. Dietary changes can help reduce this risk. Liver cirrhosis is the ...

Researchers at Karolinska Institutet and the University of Gothenburg in Sweden have made a groundbreaking discovery about ...